However, the clinical utility of resistin is moderated by significant heterogeneity influenced by comorbidities such as renal dysfunction, ethnic variations driven by genetic polymorphisms, and the specific cardiovascular disease subtype. The gene discussed is RETN; the disease is Abnormal renal physiology.